FindTrial
Sign In

Trinpanchmooladi Ghrita Uttarbasti and Mutradahaantak Churna effect in the Pittaj Mutrakrichhra (Urinary Tract Infection)

A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Trinpanchmooladi Ghrita Uttarbasti and Mutradahaantak Churna in the Management of Pittaj Mutrakrichhra w.s.r. to Urinary Tract Infection - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/105078
Enrollment
30
Registered
2026-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

None listed

Sponsors

RGGPG Ayurvedic college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. Patients present with sign and symptoms of Pittaj Mutrakrichhra and Urinary tract infection as mentioned in diagnostic criteria. ii. Patient willing to participate. iii. Patients in the age group of 25-70 years.

Exclusion criteria

Exclusion criteria: i. Patients not willing for trial. ii. Known case of Ureteric stone, Pyelonephritis, Polycystic Kidney Disease, Neurogenic Bladder urethral stricture iii. Patient with uncontrolled Hypertension, Diabetes Mellitus, Malignancy, anorectal disease and other chronic illness. iv. Pregnant & lactating women. v. Patient suffering from chronic illness requiring immediate hospitalization. vi. Any condition which the investigator thinks may compromise with the safety of the patient

Design outcomes

Primary

MeasureTime frame
To fulfil subjective and objective criterian Efficacy and effect of trinpanchmooladi ghrita and mutradahaantak churana on growth of micro-organism causing Urinary Tract Infection. To observe untoward effect of Uttarbasti in the patients of UTI if any. To evaluate the efficacy and treatment protocol with Nitrofurantoin Timepoint: 7 days—

Secondary

MeasureTime frame
To observe untoward effect of Uttarbasti in the patients of UTI if any To evaluate the efficacy & treatment protocol with Nitrofurantoin Timepoint: 7 days—

Countries

India

Contacts

Public ContactDr Sneh Rathore

Rajiv Gandhi Government.Post Graduate College and Hospital Paprola District Kangra Himachal Pradesh

anil5karma@gmail.com9418466766

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026